{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:45:41Z","timestamp":1785149141609,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.htct.2023.11.006","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T20:46:03Z","timestamp":1703969163000},"page":"S24-S31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S5","title":["Outcomes of thrombotic thrombocytopenic purpura patients submitted to therapeutic plasma exchange in a single center in Brazil"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5322-6933","authenticated-orcid":false,"given":"Patr\u00edcia Oliveira Cunha","family":"Terra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9915-447X","authenticated-orcid":false,"given":"Gil Cunha","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7359-0174","authenticated-orcid":false,"given":"Benedito de Pina Almeida","family":"Prado J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-0864","authenticated-orcid":false,"given":"Luciana Correa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.htct.2023.11.006_bib0001","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.htct.2023.11.006_bib0002","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.htct.2023.11.006_bib0003","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.htct.2023.11.006_bib0004","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","article-title":"Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features","volume":"142","author":"Scully","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2023.11.006_bib0005","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.htct.2023.11.006_bib0006","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"17","key":"10.1016\/j.htct.2023.11.006_bib0007","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMra1813013","article-title":"Hereditary thrombotic Thrombocytopenic purpura","volume":"381","author":"Kremer Hovinga","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.htct.2023.11.006_bib0008","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.htct.2023.11.006_bib0009","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.htct.2023.11.006_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-196603000-00003","article-title":"Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature","volume":"45","author":"Amorosi","year":"1966","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.htct.2023.11.006_bib0011","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.htct.2023.11.006_bib0012","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1182\/bloodadvances.2017009308","article-title":"Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura","volume":"1","author":"Cataland","year":"2017","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.htct.2023.11.006_bib0013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/CCM.0b013e31822e9d66","article-title":"Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center","volume":"40","author":"Froissart","year":"2012","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.htct.2023.11.006_bib0014","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.htct.2023.11.006_bib0015","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3324\/haematol.2011.049676","article-title":"Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience","volume":"97","author":"Benhamou","year":"2012","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.htct.2023.11.006_bib0016","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ajh.23455","article-title":"Management and outcomes for patients with TTP: analysis of 100 cases at a single institution","volume":"88","author":"Chaturvedi","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.htct.2023.11.006_bib0017","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2014-10-605493","article-title":"Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality","volume":"125","author":"Goel","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.htct.2023.11.006_bib0018","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2014-10-605493","article-title":"Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality","volume":"125","author":"Goel","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.htct.2023.11.006_bib0019","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.amjmed.2020.06.020","article-title":"Cardiovascular complications and their association with mortality in patients with thrombotic thrombocytopenic purpura","volume":"134","author":"Balasubramaniyam","year":"2021","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.htct.2023.11.006_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260196","article-title":"Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura","volume":"16","author":"Renaud","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.htct.2023.11.006_bib0021","doi-asserted-by":"crossref","first-page":"E644","DOI":"10.1002\/ajh.24885","article-title":"Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10 %-20 %","volume":"92","author":"Ayanambakkam","year":"2017","journal-title":"Am J Hematol"},{"issue":"14","key":"10.1016\/j.htct.2023.11.006_bib0022","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood.2020009150","article-title":"Redefining outcomes in immune TTP: an international working group consensus report","volume":"137","author":"Cuker","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.htct.2023.11.006_bib0023","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/s-0039-1679907","article-title":"Clinical and laboratory features of patients with acquired thrombotic thrombocytopenic purpura: fourteen years of the milan TTP registry","volume":"119","author":"Mancini","year":"2019","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.htct.2023.11.006_bib0024","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/bloodadvances.2017005124","article-title":"Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015","volume":"1","author":"Page","year":"2017","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.htct.2023.11.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272290","article-title":"Neurological manifestations in thrombotic microangiopathy: imaging features, risk factors and clinical course","volume":"17","author":"de Castro","year":"2022","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.htct.2023.11.006_bib0026","doi-asserted-by":"crossref","first-page":"834","DOI":"10.5858\/2003-127-834-TTPAHU","article-title":"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases","volume":"127","author":"Hosler","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.htct.2023.11.006_bib0027","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4330\/wjc.v10.i12.254","article-title":"Cardiac implications of thrombotic thrombocytopenic purpura","volume":"10","author":"Wiernek","year":"2018","journal-title":"World J Cardiol"},{"issue":"1","key":"10.1016\/j.htct.2023.11.006_bib0028","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3324\/haematol.2018.198275","article-title":"Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura","volume":"104","author":"Staley","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.htct.2023.11.006_bib0029","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12185-021-03197-5","article-title":"Strong association between insufficient plasma exchange and fatal outcomes in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura","volume":"114","author":"Kayashima","year":"2021","journal-title":"Int J Hematol"},{"issue":"8","key":"10.1016\/j.htct.2023.11.006_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256024","article-title":"Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era","volume":"16","author":"Van de Louw","year":"2021","journal-title":"PLoS One"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923026068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923026068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T06:10:23Z","timestamp":1732947023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137923026068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":30,"alternative-id":["S2531137923026068"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2023.11.006","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of thrombotic thrombocytopenic purpura patients submitted to therapeutic plasma exchange in a single center in Brazil","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2023.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}